ALK-positive Non-small Cell Lung Cancer (NSCLC)
Also known as: ALK Positive Non-small Cell Lung Cancer / ALK-positive NSCLC / ALK-positive Non-small Cell Lung Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09063 | Ceritinib | 1 | Active Not Recruiting | 1 |
DB08865 | Crizotinib | 1 | Completed | 1 |
DB14860 | Ensartinib | 1 | Unknown Status | 1 |
DB01167 | Itraconazole | 1 | Completed | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB01045 | Rifampicin | 1 | Completed | 1 |
DB13104 | X-396 | 1 | Unknown Status | 1 |
DB11363 | Alectinib | 1 / 2 | Terminated | 1 |
DB09063 | Ceritinib | 2 | Completed | 1 |
DB09063 | Ceritinib | 2 | Terminated | 1 |
DB12130 | Lorlatinib | 2 | Recruiting | 1 |
DB08865 | Crizotinib | 3 | Unknown Status | 1 |
DB11363 | Alectinib | Not Available | Completed | 1 |
DB12267 | Brigatinib | Not Available | Completed | 1 |
DB09063 | Ceritinib | Not Available | Completed | 1 |
DB08865 | Crizotinib | Not Available | Completed | 1 |
DB12130 | Lorlatinib | Not Available | Completed | 2 |